The American Pharmacists Association (APhA) has launched new and current training programs and resources to assist responders on the front lines of health care in staying safe and up to date with the latest research and practice guidance for the COVID-19 pandemic, it was reported on Tuesday.
APhA vice president, Professional Education Resources, Daniel Zlott, PharmD, BCOP, said, 'We are diligently working on behalf of pharmacists and patients to address the training needs of all as we face unprecedented times. Pharmacists can assist patients in a number of ways, including helping to increase the number of individuals who are able to be tested for COVID-19 and providing education to patients.'
The APhA's COVID-19 Specimen Collection Training guides pharmacists through the collection of nasopharyngeal swabs. The program will be adaptable to other testing methods once they become more widely available, such as nasal swabs, oral swabs, fingerstick tests, and other new technologies.
Avidity Biosciences prices upsized common stock public offering
Sanofi's SAR402663 granted FDA fast track designation for wet AMD
Endo to share PFI and PFA data at American Orthopaedic Foot & Ankle Society Annual Meeting
Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes
Sobi's Biologics License Application for NASP in uncontrolled gout accepted by FDA
Hydrosome Labs announces promising fermentation breakthrough with ultrafine bubbles
Ionis receives FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
AMO Pharma signs licence agreement with PHRI and Venca Research Inc to advance new study in ARVC
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD
Amgen and Kyowa Kirin release rocatinlimab study results in atopic dermatitis
Hemogenyx Pharmaceuticals partners with Made Scientific to advance CAR-T therapy
Lilly's Jaypirca delivers breakthrough results in front-line CLL trial